Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 5/20 | 0.32 |
| ▸ | CA1 | P00915 | 5/20 | 0.32 |
| ▸ | CA2 | P00918 | 5/20 | 0.32 |
| ▸ | CA9 | Q16790 | 5/20 | 0.32 |
| ▸ | CA7 | P43166 | 3/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8169613 | 1.00 | TSHR (0.46) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL3815702 | 0.91 | TSHR (0.38) | TSHR | |
| SCHEMBL3653326 | 0.89 | TSHR (0.37) | TSHRHCAR2 | |
| SCHEMBL36670 | 0.85 | TSHR (0.59) | TSHRHCAR2CA12CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL16191762 | 0.82 | TSHR (0.56) | TSHRHCAR2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL15092480 | 0.82 | TSHR (0.56) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL6726188 | 0.82 | TSHR (0.56) | TSHRHCAR2CA12CA1CA2 | |
| Water SCHEMBL27755453 | 0.82 | TSHR (0.56) | TSHRHCAR2CA12CA1CA2 | |
| SCHEMBL6729295 | 0.82 | TSHR (0.56) | TSHRHCAR2CA12CA1CA2 | |
| Hydrogen Peroxide SCHEMBL28342534 | 0.82 | TSHR (0.56) | TSHRHCAR2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119147674-A | Method for detecting halogenated ester in cefamate drug | 浙江普洛得邦制药有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-115197242-B | Preparation method of cefpodoxime proxetil impurity I | 艾美科健（中国）生物医药有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115093431-B | Method for synthesizing cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-114478391-B | Ornidazole ester prodrug, pharmaceutical composition, and preparation method and application thereof | 南京锐志生物医药有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-115197242-A | Preparation method of cefpodoxime proxetil impurity I | 艾美科健（中国）生物医药有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-115093431-A | Method for synthesizing cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-113999252-A | Cefpodoxime proxetil impurity cefpodoxime dippivoxil and preparation method thereof | 浙江东邦药业有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-108440570-B | Preparation method of ceftiofur ester compound or halogen salt thereof | 济宁市化工研究院 | 2020-12-04 | — | — | CN | claimed |
| WO-2010097675-A1 | AN IMPROVED PREPARATION PROCESS FOR CEFPODOXIME PROXETIL | DHANUKA LABORATORIES LTD. (IN) | 2010-09-02 | — | — | WO | claimed |
| US-7045618-B2 | Cefpodixime proxetil | RANBAXY LABORATORIES LIMITED (IN) | 2006-05-16 | — | — | US | claimed |
| EP-1228074-B1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM IND CO LTD (KR) | 2005-06-15 | — | — | EP | claimed |
| EP-1373276-A4 | PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | RANBAXY LAB LTD (IN) | 2005-03-02 | — | — | EP | claimed |
| US-20040092734-A1 | Cefpodixime proxetil | LOTUS PHARMACEUTICAL CO., LTD. (JP) | 2004-05-13 | — | — | US | claimed |
| EP-1373276-A1 | PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | Ranbaxy Laboratories Limited (IN) | 2004-01-02 | — | — | EP | claimed |
| US-6639068-B1 | Reacting cefpodoxime salt with 1-iodoethylisopropylcarbonate in presence of a crown ether | HANMI PHARM. CO., LTD. (KR) | 2003-10-28 | — | — | US | claimed |
| EP-1228074-A4 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM IND CO LTD (KR) | 2003-02-26 | — | — | EP | claimed |
| WO-2002068429-A1 | PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | RANBAXY LABORATORIES LIMITED (IN) | 2002-09-06 | — | — | WO | claimed |
| EP-1228074-A1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | Hanmi Pharm. Co., Ltd. (KR) | 2002-08-07 | — | — | EP | claimed |
| WO-2001034611-A1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM. CO., LTD. (KR) | 2001-05-17 | — | — | WO | claimed |
| JP-60004190-A | — | — | None | — | — | JP | disclosed |
| CN-122070276-A | Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same | 人类生物科学股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4705289-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | Terran Biosciences Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| CN-120398914-A | Preparation method of cefpodoxime proxetil | 苏州东瑞制药有限公司 | 2025-08-01 | — | — | CN | disclosed |
| CN-120309632-A | Preparation method of cefpodoxime proxetil | 成都倍特药业股份有限公司 | 2025-07-15 | — | — | CN | disclosed |
| CN-119147674-A | Method for detecting halogenated ester in cefamate drug | 浙江普洛得邦制药有限公司 | 2024-12-17 | — | — | CN | disclosed |
| WO-2024226691-A1 | PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF | TERRAN BIOSCIENCES INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-118852204-A | Purification method of cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-114728883-B | Ibuprofen ester prodrug, pharmaceutical composition, preparation method and application | 南京海融医药科技股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-115197242-B | Preparation method of cefpodoxime proxetil impurity I | 艾美科健（中国）生物医药有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-114746394-B | Aryl propionic acid derivative, pharmaceutical composition, and preparation method and application thereof | 南京海融医药科技股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117417352-A | Preparation method of cefpodoxime proxetil impurity E | 湖北凌晟药业股份有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-115093431-B | Method for synthesizing cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-115093431-B | Method for synthesizing cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-114478391-B | Ornidazole ester prodrug, pharmaceutical composition, and preparation method and application thereof | 南京锐志生物医药有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20230000812-A1 | IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION | NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) | 2023-01-05 | — | — | US | disclosed |
| CN-115197242-A | Preparation method of cefpodoxime proxetil impurity I | 艾美科健（中国）生物医药有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-115093431-A | Method for synthesizing cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-115093431-A | Method for synthesizing cefpodoxime proxetil | 艾美科健（中国）生物医药有限公司 | 2022-09-23 | — | — | CN | disclosed |
| US-20220274911-A1 | ARYLPROPIONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND APPLICATION THEREOF | NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) | 2022-09-01 | — | — | US | disclosed |
| CN-114746394-A | Aryl propionic acid derivative, pharmaceutical composition, preparation method and application thereof | 南京海融医药科技股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-113185538-B | Preparation method of cefpodoxime acid | 山东昌邑四方医药化工有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-114728883-A | Ibuprofen ester prodrug, pharmaceutical composition, preparation method and application | 南京海融医药科技股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-4001258-A1 | ARYL PROPIONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND METHOD FOR PREPARATION THEREOF AND APPLICATION THEREOF | Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. (CN) | 2022-05-25 | — | — | EP | disclosed |
| CN-114478391-A | Ornidazole ester prodrug, pharmaceutical composition, preparation method and application thereof | 南京锐志生物医药有限公司 | 2022-05-13 | — | — | CN | disclosed |
| EP-3984989-A1 | IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND USE | Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. (CN) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022052936-A1 | ARYL PROPIONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND METHOD FOR PREPARATION THEREOF AND APPLICATION THEREOF | 南京海融医药科技股份有限公司 | 2022-03-17 | — | — | WO | disclosed |
| CN-113999252-A | Cefpodoxime proxetil impurity cefpodoxime dippivoxil and preparation method thereof | 浙江东邦药业有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113999252-A | Cefpodoxime proxetil impurity cefpodoxime dippivoxil and preparation method thereof | 浙江东邦药业有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113185538-A | Preparation method of cefpodoxime acid | 山东昌邑四方医药化工有限公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-108440570-B | Preparation method of ceftiofur ester compound or halogen salt thereof | 济宁市化工研究院 | 2020-12-04 | — | — | CN | disclosed |
| CN-108440570-B | Preparation method of ceftiofur ester compound or halogen salt thereof | 济宁市化工研究院 | 2020-12-04 | — | — | CN | disclosed |
| EP-2857385-B1 | PRODRUG OF FLUORINE-CONTAINING AMINO ACID | TAISHO PHARMACEUTICAL CO LTD (JP) | 2017-08-02 | — | — | EP | disclosed |
| EP-2548871-B1 | CYCLOALKYL-SUBSTITUTED IMIDAZOLE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2017-07-19 | — | — | EP | disclosed |
| EP-2548871-B1 | CYCLOALKYL-SUBSTITUTED IMIDAZOLE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2017-07-19 | — | — | EP | disclosed |
| WO-2017046756-A1 | PROXETIL AND AXETIL ESTERS OF CEFIXIME | LUPIN LIMITED (IN) | 2017-03-23 | — | — | WO | disclosed |
| CN-106365997-A | Preparation method of 1-iodoethylisopropylcarbonate | 陕西思尔生物科技有限公司 | 2017-02-01 | — | — | CN | disclosed |
| CN-106365997-A | Preparation method of 1-iodoethylisopropylcarbonate | 陕西思尔生物科技有限公司 | 2017-02-01 | — | — | CN | disclosed |
| CN-105801489-A | Cycloalkyl-substituted imidazole derivative | 第三共株式会社 | 2016-07-27 | — | — | CN | disclosed |
| US-9340531-B2 | Cycloalkyl-substituted imidazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9340531-B2 | Cycloalkyl-substituted imidazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9340531-B2 | Cycloalkyl-substituted imidazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-05-17 | — | — | US | disclosed |
| WO-2015108835-A1 | 3,3-DISUBSTITUTED-1-HYDROXYTRIAZ-1-ENE 2-OXIDES AND WOUND-HEALING COMPOSITIONS USING THEM | SARMONT LLC (US) | 2015-07-23 | — | — | WO | disclosed |
| WO-2015108835-A1 | 3,3-DISUBSTITUTED-1-HYDROXYTRIAZ-1-ENE 2-OXIDES AND WOUND-HEALING COMPOSITIONS USING THEM | SARMONT LLC (US) | 2015-07-23 | — | — | WO | disclosed |
| US-20150119373-A1 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | HETERO LABS LIMITED (IN) | 2015-04-30 | — | — | US | disclosed |
| US-20150119373-A1 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | HETERO LABS LIMITED (IN) | 2015-04-30 | — | — | US | disclosed |
| US-20150119373-A1 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | HETERO LABS LIMITED (IN) | 2015-04-30 | — | — | US | disclosed |
| EP-2857385-A1 | PRODRUG OF FLUORINE-CONTAINING AMINO ACID | Taisho Pharmaceutical Co., Ltd. (JP) | 2015-04-08 | — | — | EP | disclosed |
| US-8859781-B2 | No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents | Euclises Pharmaceuticals, Inc. (US) | 2014-10-14 | — | — | US | disclosed |
| US-8859781-B2 | No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents | Euclises Pharmaceuticals, Inc. (US) | 2014-10-14 | — | — | US | disclosed |
| US-8859781-B2 | No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents | Euclises Pharmaceuticals, Inc. (US) | 2014-10-14 | — | — | US | disclosed |
| US-20140178349-A1 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-26 | — | — | US | disclosed |
| US-8658639-B2 | N-substituted-cyclic amino derivative | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2014-02-25 | — | — | US | disclosed |
| US-8658639-B2 | N-substituted-cyclic amino derivative | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2014-02-25 | — | — | US | disclosed |
| US-8658639-B2 | N-substituted-cyclic amino derivative | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2014-02-25 | — | — | US | disclosed |
| WO-2014012074-A2 | NO-RELEASING NONOATE (NITROGEN-BOUND) SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS | Euclises Pharmaceuticals, Inc. (US) | 2014-01-16 | — | — | WO | disclosed |
| US-20140018544-A1 | NO-RELEASING NONOATE(NITROGEN-BOUND)SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS | Euclises Pharmaceuticals, Inc. | 2014-01-16 | — | — | US | disclosed |
| WO-2014012074-A2 | NO-RELEASING NONOATE (NITROGEN-BOUND) SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS | Euclises Pharmaceuticals, Inc. (US) | 2014-01-16 | — | — | WO | disclosed |
| US-20140018544-A1 | NO-RELEASING NONOATE(NITROGEN-BOUND)SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS | Euclises Pharmaceuticals, Inc. | 2014-01-16 | — | — | US | disclosed |
| US-20140018544-A1 | NO-RELEASING NONOATE(NITROGEN-BOUND)SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS | Euclises Pharmaceuticals, Inc. | 2014-01-16 | — | — | US | disclosed |
| US-8609710-B2 | Cycloalkyl-substituted imidazole derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-12-17 | — | — | US | disclosed |
| WO-2013160810-A2 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2013-10-31 | — | — | WO | disclosed |
| WO-2013160810-A2 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | HETERO RESEARCH FOUNDATION (IN) | 2013-10-31 | — | — | WO | disclosed |
| US-20130230501-A9 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130230501-A9 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130230501-A9 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20130022587-A1 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20130022587-A1 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20130022587-A1 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| EP-2548871-A1 | CYCLOALKYL-SUBSTITUTED IMIDAZOLE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-23 | — | — | EP | disclosed |
| US-8344154-B2 | 2-thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2013-01-01 | — | — | US | disclosed |
| EP-2520578-A1 | Process for purification of cephalosporins | Lupin Limited (IN) | 2012-11-07 | — | — | EP | disclosed |
| US-8217013-B2 | Polyene diester antibiotics | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2012-07-10 | — | — | US | disclosed |
| WO-2012079504-A1 | PROCESS FOR PREPARING CARBAPENEM ANTIBIOTICS | 石药集团中奇制药技术（石家庄）有限公司 (CN) | 2012-06-21 | — | — | WO | disclosed |
| US-20120122773-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| US-20120122773-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| US-20120122773-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| EP-2447264-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-2447264-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20110118229-A1 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KUKJE PHARM. IND. CO., LTD. (KR) | 2011-05-19 | — | — | US | disclosed |
| US-20110118229-A1 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KUKJE PHARM. IND. CO., LTD. (KR) | 2011-05-19 | — | — | US | disclosed |
| US-20110118229-A1 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KUKJE PHARM. IND. CO., LTD. (KR) | 2011-05-19 | — | — | US | disclosed |
| WO-2010097675-A1 | AN IMPROVED PREPARATION PROCESS FOR CEFPODOXIME PROXETIL | DHANUKA LABORATORIES LTD. (IN) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010097675-A1 | AN IMPROVED PREPARATION PROCESS FOR CEFPODOXIME PROXETIL | DHANUKA LABORATORIES LTD. (IN) | 2010-09-02 | — | — | WO | disclosed |
| US-20100210576-A1 | POLYENE DIESTER ANTIBIOTICS | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY | 2010-08-19 | — | — | US | disclosed |
| EP-2212325-A2 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Kukje Pharm. Ind. Co., Ltd. (KR) | 2010-08-04 | — | — | EP | disclosed |
| US-20100145063-A1 | 2- thioethenyl substituted carbapenem derivatives | MARUYAMA TAKAHISA | 2010-06-10 | — | — | US | disclosed |
| EP-2174944-A1 | POLYENE DIESTER ANTIBIOTICS | Shanghai Institute of Pharmaceutical Industry (CN) | 2010-04-14 | — | — | EP | disclosed |
| US-7687490-B2 | 2-thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2010-03-30 | — | — | US | disclosed |
| WO-2009066917-A2 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KUKJE PHARM. IND. CO., LTD. (KR) | 2009-05-28 | — | — | WO | disclosed |
| WO-2009066917-A2 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KUKJE PHARM. IND. CO., LTD. (KR) | 2009-05-28 | — | — | WO | disclosed |
| EP-1409492-B1 | AN IMPROVED METHOD FOR PREPARATION OF CEFUROXIME AXETIL | LUPIN LTD (IN) | 2008-10-15 | — | — | EP | disclosed |
| US-20080227803-A1 | Indolomorphinan Derivative Having Carboxy in 6'-Position | SHIOONOGI & CO., LTD., A LEGAL ENTITY OF JAPAN (JP) | 2008-09-18 | — | — | US | disclosed |
| US-7317101-B2 | Antibacterial cephalosporins | SANDOZ GMBH (AT) | 2008-01-08 | — | — | US | disclosed |
| EP-1870412-A1 | 2-THIOETHENYL CARBAPENEM DERIVATIVE | MEIJI SEIKA KAISHA LTD. (JP) | 2007-12-26 | — | — | EP | disclosed |
| EP-1590353-B1 | A PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | LUPIN LTD (IN) | 2007-10-10 | — | — | EP | disclosed |
| EP-1590353-B1 | A PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | LUPIN LTD (IN) | 2007-10-10 | — | — | EP | disclosed |
| EP-1837022-A1 | INDOLOMORPHINAN DERIVATIVE HAVING CARBOXY IN 6'-POSITION | Shionogi Co., Ltd. (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070099890-A1 | Novel cephalosporin derivatives, its pharmaceutically acceptable salts and manufacturing process thereof | YUGJIN PHARMACEUTICAL CO., LTD (KR) | 2007-05-03 | — | — | US | disclosed |
| US-20070004700-A1 | 2-Thioethenyl substituted carbapenem derivatives | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20060293296-A1 | Process for the preparation of cefpodoxime procetil | LUPIN LIMITED (IN) | 2006-12-28 | — | — | US | disclosed |
| EP-1340757-B1 | 1-METHYLCARBAPENEM DERIVATIVES | SANKYO CO (JP) | 2006-10-11 | — | — | EP | disclosed |
| US-20060223789-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | NABRIVA THERAPEUTICS AG (AT) | 2006-10-05 | — | — | US | disclosed |
| US-20060149055-A1 | Process for the manufacture of cefpodoxime proxetil | LUPIN LIMITED (IN) | 2006-07-06 | — | — | US | disclosed |
| US-7064198-B2 | Method for preparation of cefuroxime axetil | LUPIN LIMITED (IN) | 2006-06-20 | — | — | US | disclosed |
| US-7045618-B2 | Cefpodixime proxetil | RANBAXY LABORATORIES LIMITED (IN) | 2006-05-16 | — | — | US | disclosed |
| US-7001897-B2 | 1-methylcarbapenem derivatives | SANKYO COMPANY, LIMITED (JP) | 2006-02-21 | — | — | US | disclosed |
| US-20060009639-A1 | Process for the preparation of cefpodoxime proxetil | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2006-01-12 | — | — | US | disclosed |
| EP-1590353-A1 | A PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | Lupin Limited (IN) | 2005-11-02 | — | — | EP | disclosed |
| EP-1583764-A1 | A PROCESS FOR THE MANUFACTURE OF CEFPODOXIME PROXETIL | Lupin Limited (IN) | 2005-10-12 | — | — | EP | disclosed |
| EP-1228074-B1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM IND CO LTD (KR) | 2005-06-15 | — | — | EP | disclosed |
| EP-1228074-B1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM IND CO LTD (KR) | 2005-06-15 | — | — | EP | disclosed |
| EP-1373276-A4 | PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | RANBAXY LAB LTD (IN) | 2005-03-02 | — | — | EP | disclosed |
| WO-2005000853-A1 | NOVEL CEPHALOSPORIN DERIVATIVES, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND MANUFACTURING PROCESS THEREOF | YUNGJIN PHARMACEUTICAL CO., LTD. (KR) | 2005-01-06 | — | — | WO | disclosed |
| US-20040248941-A1 | Benzimidazone compound, process for producing the same, and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-12-09 | — | — | US | disclosed |
| CN-1160361-C | Method for prepairng highly purity cefpodoxime proxetil | ����ҩƷ��ҵ��ʽ���� | 2004-08-04 | — | — | CN | disclosed |
| WO-2004060896-A1 | A PROCESS FOR THE MANUFACTURE OF CEFPODOXIME PROXETIL | LUPIN LIMITED (IN) | 2004-07-22 | — | — | WO | disclosed |
| EP-1437352-A1 | BENZIMIDAZOLE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-07-14 | — | — | EP | disclosed |
| US-20040132709-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | ASCHER GERD (AT) | 2004-07-08 | — | — | US | disclosed |
| WO-2004056834-A1 | A PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | LUPIN LIMITED (IN) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004048387-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2004-06-10 | — | — | WO | disclosed |
| US-20040092734-A1 | Cefpodixime proxetil | LOTUS PHARMACEUTICAL CO., LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| US-20040077850-A1 | Method for preparation of cefuroxime axetil | LUPIN LIMITED (IN) | 2004-04-22 | — | — | US | disclosed |
| EP-1409492-A1 | AN IMPROVED METHOD FOR PREPARATION OF CEFUROXIME AXETIL | Lupin Limited (IN) | 2004-04-21 | — | — | EP | disclosed |
| US-6693095-B2 | 7-(((5-AMINO-1,2,4-THIADIAZOL-3-YL)-(Z)-(FLUORMETHOXYIMINO) -ACETYL)AMINO)-3(E)-((IMINO-1-PIPERAZINYLMETHYL)-METHYLHYDRAZONO)METHYL-3 -CEPHEM-4-CARBOXYLIC ACID TRIHYDROCHLORIDE FOR EXAMPLE | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2004-02-17 | — | — | US | disclosed |
| WO-2004011471-A1 | PROCESS FOR THE PREPARATION OF CEPHEM ESTERS | RANBAXY LABORATORIES LIMITED (IN) | 2004-02-05 | — | — | WO | disclosed |
| US-20040014962-A1 | 1-Methylcarbapenem derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-01-22 | — | — | US | disclosed |
| US-6677331-B2 | HAVING SUBSTITUTED IMIDAZO(5,1-B)THIAZOLE GROUP AT 2-POSITION; MICROBIOCIDES AGAINST BETA-LACTAMASE PRODUCING BACTERIA AND RESISTANT PSEUDOMONAS | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-01-13 | — | — | US | disclosed |
| EP-1373276-A1 | PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | Ranbaxy Laboratories Limited (IN) | 2004-01-02 | — | — | EP | disclosed |
| US-6639068-B1 | Reacting cefpodoxime salt with 1-iodoethylisopropylcarbonate in presence of a crown ether | HANMI PHARM. CO., LTD. (KR) | 2003-10-28 | — | — | US | disclosed |
| US-6639068-B1 | Reacting cefpodoxime salt with 1-iodoethylisopropylcarbonate in presence of a crown ether | HANMI PHARM. CO., LTD. (KR) | 2003-10-28 | — | — | US | disclosed |
| US-20030191105-A1 | Antibacterial cephalosporins | NABRIVA THERAPEUTICS AG (AT) | 2003-10-09 | — | — | US | disclosed |
| EP-1340757-A1 | 1-METHYLCARBAPENEM DERIVATIVES | Sankyo Company, Limited (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-20030149016-A1 | Novel carbapenem derivatives | KANO YUKO (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-0973780-B1 | ANTIBACTERIAL SUBSTITUTED 7-ACYLAMINO -3-(METHYLHYDRAZONO) METHYL-CEPHALOSPORINS AND INTERMEDIATES | BIOCHEMIE GMBH (AT) | 2003-07-02 | — | — | EP | disclosed |
| US-20030114665-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | ASCHER GERD (AT) | 2003-06-19 | — | — | US | disclosed |
| EP-1300408-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono)methyl-cephalosporins and intermediates | BIOCHEMIE Gesellschaft m.b.H. (AT) | 2003-04-09 | — | — | EP | disclosed |
| US-6531465-B1 | 7-acylamino-3-(imino)methyl cephalosporins; 7-[[(5-Amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluormethoxyimino)acetyl]amino]-3-[[(piperazinoiminomethyl)hydrazono]methyl]-3-cephem-4-carboxylic acid; imination of 3-methyl derivative; acylation at the 7-amino; 1-[hydrazino(methylimino)methyl]piperazine intermediate | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2003-03-11 | — | — | US | disclosed |
| EP-1228074-A4 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM IND CO LTD (KR) | 2003-02-26 | — | — | EP | disclosed |
| EP-1228074-A4 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM IND CO LTD (KR) | 2003-02-26 | — | — | EP | disclosed |
| EP-0824535-B1 | ANTIBACTERIAL CEPHALOSPORINS | BIOCHEMIE GMBH (AT) | 2003-02-26 | — | — | EP | disclosed |
| WO-2003010170-A1 | AN IMPROVED METHOD FOR PREPARATION OF CEFUROXIME AXETIL | LUPIN LIMITED (IN) | 2003-02-06 | — | — | WO | disclosed |
| CN-1387533-A | Method for prepairng highly purity cefpodoxime proxetil | HANMI PHARM IND CO LTD (KR) | 2002-12-25 | — | — | CN | disclosed |
| US-6458780-B1 | IMIDAZO(5,1-B)THIAZOLE GROUP AT THE 2-POSITION ON THE CARBAPENEM RING HAVE HIGH ANTI-MICROBIAL ACTIVITIES AGAINST .BETA.-LACTAMASE PRODUCING BACTERIA, MRSA, RESISTANT-PSEUDOMONAS AERUGINOSA, PRSP, ENTEROCOCCI, AND | MEIJI SEIKA KAISHA, LTD. (JP) | 2002-10-01 | — | — | US | disclosed |
| WO-2002068429-A1 | PROCESS FOR THE PREPARATION OF CEFPODOXIME PROXETIL | RANBAXY LABORATORIES LIMITED (IN) | 2002-09-06 | — | — | WO | disclosed |
| EP-1022279-B1 | NEW CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
| US-20020115852-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | ASCHER GERD (AT) | 2002-08-22 | — | — | US | disclosed |
| EP-1228074-A1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | Hanmi Pharm. Co., Ltd. (KR) | 2002-08-07 | — | — | EP | disclosed |
| EP-1228074-A1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | Hanmi Pharm. Co., Ltd. (KR) | 2002-08-07 | — | — | EP | disclosed |
| US-20020091252-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | NABRIVA THERAPEUTICS AG (AT) | 2002-07-11 | — | — | US | disclosed |
| EP-1221446-A1 | Antibacterial cephalosporins | BIOCHEMIE Gesellschaft m.b.H. (AT) | 2002-07-10 | — | — | EP | disclosed |
| US-6310056-B1 | 2-SUBSTITUTED WITH A IMIDAZO(5,1-B)THIAZOLE GROUP; TREATING INFECTIONS, INCLUDING ANTIBIOTIC RESISTANT BACTERIAL INFECTIONS | MEIJI SEIKA KAISHA, LTD. (JP) | 2001-10-30 | — | — | US | disclosed |
| CN-1315955-A | Novel carbapenem derivatives | MEIJI SEIKA KAISHA (JP) | 2001-10-03 | — | — | CN | disclosed |
| WO-2001062242-A1 | PRODRUGS OF SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| EP-1101766-A1 | NOVEL CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA LTD. (JP) | 2001-05-23 | — | — | EP | disclosed |
| WO-2001034611-A1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM. CO., LTD. (KR) | 2001-05-17 | — | — | WO | disclosed |
| WO-2001034611-A1 | METHOD OF PREPARING HIGHLY PURE CEFPODOXIME PROXETIL | HANMI PHARM. CO., LTD. (KR) | 2001-05-17 | — | — | WO | disclosed |
| EP-0484966-B1 | 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation | EISAI CO LTD (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-0761671-B1 | Cephem derivatives | EISAI CO LTD (JP) | 2001-04-04 | — | — | EP | disclosed |
| EP-1074553-A1 | 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation | Eisai Co., Ltd. (JP) | 2001-02-07 | — | — | EP | disclosed |
| EP-1074554-A2 | 7-acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation | Eisai Co., Ltd. (JP) | 2001-02-07 | — | — | EP | disclosed |
| EP-1022279-A1 | NEW CARBAPENEM DERIVATIVES | MEIJI SEIKA KAISHA LTD. (JP) | 2000-07-26 | — | — | EP | disclosed |
| EP-1019405-A1 | BETA-METHYLCARBAPENEM DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Korea Research Institute of Chemical Technology (KR) | 2000-07-19 | — | — | EP | disclosed |
| US-6077952-A | Cephaloporins and homologues | PFIZER INC. (US) | 2000-06-20 | — | — | US | disclosed |
| US-6020329-A | Cephaloporins and homologues, preparations and pharmaceutical compositions | PZIFER INC. (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0973780-A1 | ANTIBACTERIAL SUBSTITUTED 7-ACYLAMINO -3-(METHYLHYDRAZONO) METHYL-CEPHALOSPORINS AND INTERMEDIATES | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2000-01-26 | — | — | EP | disclosed |
| US-6001997-A | Cephalosporins and homologues, preparations and pharmaceutical compositions | BATESON JOHN HARGREAVES (GB) | 1999-12-14 | — | — | US | disclosed |
| US-5973188-A | Acetic acid derivatives | HOFFMANN-LA ROCHE INC. (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1998043981-A1 | ANTIBACTERIAL SUBSTITUTED 7-ACYLAMINO-3-(METHYLHYDRAZONO)METHYL -CEPHALOSPORINS AND INTERMEDIATES | BIOCHEMIE GESELLSCHAFT MBH (AT) | 1998-10-08 | — | — | WO | disclosed |
| US-5741902-A | INTERMEDIATES FOR CEPHEM ANTIBACTERIAL COMPOUNDS | EISAI CO., LTD. (JP) | 1998-04-21 | — | — | US | disclosed |
| EP-0474243-B1 | 1-Methylcarbapenem derivatives and process for preparation thereof | TANABE SEIYAKU CO (JP) | 1998-04-01 | — | — | EP | disclosed |
| US-5726185-A | BINDING OF ADHESIVE PROTEINS TO BLOOD PLATELET AGGREGATION AND CELL TO CELL ADHESION | HOFFMANN-LA ROCHE INC. (US) | 1998-03-10 | — | — | US | disclosed |
| EP-0824535-A1 | ANTIBACTERIAL CEPHALOSPORINS | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 1998-02-25 | — | — | EP | disclosed |
| EP-0681580-B1 | PRODRUGS OF ANTIINFLAMMATORY 3-ACYL-2-OXINDOLE-1-CARBOXAMIDES | PFIZER (US) | 1997-07-09 | — | — | EP | disclosed |
| WO-1997020844-A1 | β-METHYLCARBAPENEM DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1997-06-12 | — | — | WO | disclosed |
| EP-0761671-A1 | Cephem derivatives | Eisai Co., Ltd. (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5604217-A | CEPHALOSPORIN ANTIBIOTICS | EISAI CO., LTD. (JP) | 1997-02-18 | — | — | US | disclosed |
| US-5587473-A | BLOCKING; CONDENSATION; DEBLOCKING | EISAI CO., LTD. (JP) | 1996-12-24 | — | — | US | disclosed |
| WO-1996035692-A1 | ANTIBACTERIAL CEPHALOSPORINS | BIOCHEMIE GESELLSCHAFT MBH (AT) | 1996-11-14 | — | — | WO | disclosed |
| US-5563265-A | BACTERICIDES | EISAI CO., LTD. (JP) | 1996-10-08 | — | — | US | disclosed |
| US-5559225-A | ANTIBIOTICS | EISAI CO., LTD. (JP) | 1996-09-24 | — | — | US | disclosed |
| EP-0408034-B1 | 3-Substituted vinyl cephalosporin derivatives | EISAI CO LTD (JP) | 1996-05-01 | — | — | EP | disclosed |
| EP-0681580-A1 | PRODRUGS OF ANTIINFLAMMATORY 3-ACYL-2-OXINDOLE-1-CARBOXAMIDES. | PFIZER HOSPITAL PROD (US) | 1995-11-15 | — | — | EP | disclosed |
| US-5389626-A | 3-aryloxmethyl-cephalosporin derivatives, and their medical use | SANKYO COMPANY, LIMITED (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0337637-B1 | 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics | SANKYO CO (JP) | 1994-11-30 | — | — | EP | disclosed |
| WO-1994017061-A1 | PRODRUGS OF ANTIINFLAMMATORY 3-ACYL-2-OXINDOLE-1-CARBOXAMIDES | PFIZER INC. (US) | 1994-08-04 | — | — | WO | disclosed |
| EP-0597821-A1 | 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics | Sankyo Company Limited (JP) | 1994-05-18 | — | — | EP | disclosed |
| US-5270331-A | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides | PFIZER, INC. (US) | 1993-12-14 | — | — | US | disclosed |
| US-5242914-A | 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics | SANKYO COMPANY, LIMITED (JP) | 1993-09-07 | — | — | US | disclosed |
| US-5208348-A | Intermediates for thienamycin derivatives | TANABE SEIYAKU CO., LTD. (JP) | 1993-05-04 | — | — | US | disclosed |
| US-5153187-A | Microbiocides having stability against dehydropeptidase and high absorrbability by oral administration | TANABE SEIYAKU CO., LTD. (JP) | 1992-10-06 | — | — | US | disclosed |
| US-5151417-A | Antibiotics and bactericides | EISAI CO., LTD. (JP) | 1992-09-29 | — | — | US | disclosed |
| EP-0484966-A2 | 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation | Eisai Co., Ltd. (JP) | 1992-05-13 | — | — | EP | disclosed |
| EP-0482657-A2 | Cephem compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1992-04-29 | — | — | EP | disclosed |
| US-5104867-A | 2-(HETEROCYCLYLTHIO)CARBAPENEM DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIBIOTICS | SANKYO COMPANY, LIMITED (JP) | 1992-04-14 | — | — | US | disclosed |
| EP-0474243-A1 | 1-Methylcarbapenem derivatives and process for preparation thereof | TANABE SEIYAKU CO., LTD. (JP) | 1992-03-11 | — | — | EP | disclosed |
| WO-1992001696-A1 | CEPHALOSPORINS AND HOMOLOGUES, PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS | BEECHAM GROUP PLC (GB) | 1992-02-06 | — | — | WO | disclosed |
| EP-0408034-A1 | 3-Substituted vinyl cephalosporin derivatives | Eisai Co., Ltd. (JP) | 1991-01-16 | — | — | EP | disclosed |
| US-4933355-A | ALDOSE REDUCTASE INHIBITORS | SANKYO COMPANY LIMITED (JP) | 1990-06-12 | — | — | US | disclosed |
| EP-0363223-A2 | 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use | Sankyo Company Limited (JP) | 1990-04-11 | — | — | EP | disclosed |
| EP-0337819-A1 | Thiazole derivatives, their preparation and their use in the treatment of diabetes complications | Sankyo Company Limited (JP) | 1989-10-18 | — | — | EP | disclosed |
| EP-0337637-A1 | 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics | Sankyo Company Limited (JP) | 1989-10-18 | — | — | EP | disclosed |
| JP-S604190-A | PREPARATION OF CEPHALOSPORIN DERIVATIVE | SANKYO CO LTD | 1985-01-10 | — | — | JP | disclosed |
| US-4482710-A | Process for preparing 3-alkoxymethylcephalosporin derivatives | SANKYO COMPANY LIMITED (JP) | 1984-11-13 | — | — | US | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (28 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014962-A1 | 1-Methylcarbapenem derivatives | CD14, CPT1A, ACMSD | TSHR 4873/4885HCAR2 1127/4885CA12 2412/4885 |
| US-20230000812-A1 | IBUPROFEN ESTER PRODRUG, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION | PTGER1, CYP4A11, FABP4 | TSHR 4755/4885HCAR2 539/4885CA12 3846/4885 |
| US-20140018544-A1 | NO-RELEASING NONOATE(NITROGEN-BOUND)SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS | NOS1, NOS2, PTGS1 | TSHR 2906/4885HCAR2 688/4885CA12 2841/4885 |
| US-20030114665-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | MRPL21, Q6ZSR9, EMG1 | TSHR 3472/4885HCAR2 3450/4885CA12 4665/4885 |
| US-20130022587-A1 | Cycloalkyl-Substituted Imidazole Derivative | F7, F12, TFPI | TSHR 13/4885HCAR2 237/4885CA12 2358/4885 |
| US-20040248941-A1 | Benzimidazone compound, process for producing the same, and use thereof | SI, MLNR, FABP2 | TSHR 1588/4885HCAR2 1845/4885CA12 1348/4885 |
| US-20030191105-A1 | Antibacterial cephalosporins | MRPL21, CIAPIN1, CSDE1 | TSHR 3531/4885HCAR2 3679/4885CA12 3950/4885 |
| US-20020115852-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | MRPL21, Q6ZSR9, EMG1 | TSHR 3472/4885HCAR2 3450/4885CA12 4665/4885 |
| US-20150119373-A1 | NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS | BET1, PGGT1B, RABGGTB | TSHR 4804/4885HCAR2 1219/4885CA12 4707/4885 |
| US-20100145063-A1 | 2- thioethenyl substituted carbapenem derivatives | MTAP, BLVRB, TPMT | TSHR 1626/4885HCAR2 3861/4885CA12 1331/4885 |
| US-20060293296-A1 | Process for the preparation of cefpodoxime procetil | CYP3A43, CYP2F1, PPOX | TSHR 2407/4885HCAR2 4483/4885CA12 2992/4885 |
| US-20020091252-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | MRPL21, Q6ZSR9, EMG1 | TSHR 3472/4885HCAR2 3450/4885CA12 4665/4885 |
| US-20060223789-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | MRPL21, Q6ZSR9, PRMT7 | TSHR 1996/4885HCAR2 2597/4885CA12 4718/4885 |
| US-20070004700-A1 | 2-Thioethenyl substituted carbapenem derivatives | MTAP, BLVRB, BPGM | TSHR 1341/4885HCAR2 2225/4885CA12 799/4885 |
| US-20080227803-A1 | Indolomorphinan Derivative Having Carboxy in 6'-Position | RB1, CRHR1, CRH | TSHR 124/4885HCAR2 107/4885CA12 786/4885 |
| US-20040092734-A1 | Cefpodixime proxetil | HPD, PEPD, SQLE | TSHR 4191/4885HCAR2 4178/4885CA12 3204/4885 |
| US-20070099890-A1 | Novel cephalosporin derivatives, its pharmaceutically acceptable salts and manufacturing process thereof | MRPL21, SHARPIN, CSDE1 | TSHR 4210/4885HCAR2 4699/4885CA12 3642/4885 |
| US-20030149016-A1 | Novel carbapenem derivatives | DPEP1, TMPRSS15, STK35 | TSHR 4209/4885HCAR2 3017/4885CA12 3300/4885 |
| US-20130230501-A9 | Cycloalkyl-Substituted Imidazole Derivative | F7, F12, TFPI | TSHR 13/4885HCAR2 237/4885CA12 2358/4885 |
| US-20110118229-A1 | 2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CYP2C19, CYP2C9, SCN9A | TSHR 4168/4885HCAR2 414/4885CA12 1217/4885 |
| US-20120122773-A1 | N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE | REN, AGTR1, AGTR2 | TSHR 1316/4885HCAR2 983/4885CA12 1140/4885 |
| US-20100210576-A1 | POLYENE DIESTER ANTIBIOTICS | CYP51A1, DBF4, DECR1 | TSHR 4259/4885HCAR2 1608/4885CA12 1745/4885 |
| US-20060149055-A1 | Process for the manufacture of cefpodoxime proxetil | SRR, CYP2F1, MRPL21 | TSHR 2660/4885HCAR2 3332/4885CA12 2574/4885 |
| US-20040132709-A1 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | MRPL21, Q6ZSR9, EMG1 | TSHR 3472/4885HCAR2 3450/4885CA12 4665/4885 |
| US-20040077850-A1 | Method for preparation of cefuroxime axetil | CYP2F1, MRPL21, CYP2C19 | TSHR 4738/4885HCAR2 1358/4885CA12 926/4885 |
| US-20060009639-A1 | Process for the preparation of cefpodoxime proxetil | IDE, DAO, TPO | TSHR 409/4885HCAR2 3936/4885CA12 1394/4885 |
| US-20220274911-A1 | ARYLPROPIONIC ACID DERIVATIVE, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND APPLICATION THEREOF | CYP2A7, CYP2A6, CYP3A7 | TSHR 3009/4885HCAR2 61/4885CA12 4542/4885 |
| US-20140178349-A1 | Cycloalkyl-Substituted Imidazole Derivative | F7, F12, TFPI | TSHR 13/4885HCAR2 237/4885CA12 2358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.